News, views, and reviews

Journal of Drugs in Dermatology

Volumn 7, Issue 6, 2008, Pages 597-601

  Terushkin, Vitaly ^a   Brownell, Isaac ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

COMMUNICABLE DISEASE; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PENICILLIN RESISTANCE; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 47249116459     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Daum RS. Skin and soft-tissue infections caused by methicillinresistant Staphylococcus aureus. N Engl J Med. 2007;357:380-389.
2. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666-674.
3. Elston DM. Community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Dermatol. 2007;56:1-16. (Pubitemid 44969286)
4. Purcell K, Fergie J. Epidemic of community-acquired methicillinresistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital. Arch Pediatr Adolesc Med. 2005;159: 980-985. (Pubitemid 41423339)
5. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infec Dis J. 2004;23:619-624.
6. Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin- resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis. 2007;44:777-784. (Pubitemid 46365300)
7. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA. Strategies for Clinical Management of MRSA in the Community: Summary of an Experts' Meeting Convened by the Centers for Disease Control and Prevention. March 2006.
8. Martinez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL. Clindamycin treatment of invasive infections caused by community- acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infec Dis J. 2003;22:593-598. (Pubitemid 36900204)
9. Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother. 2007;51:423-428. (Pubitemid 46185256)
10. Ruhe JJ, Monson T, Bradsher RW, Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis. 2005;40:1429-1434. (Pubitemid 40628630)
11. Chen CJ, Huang YC, Chiu CH, et al. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infec Dis J. 2005;24:40-45.
12. Weigelt J, Itani K, Stevens D, et al. Linezolid versus vancomycin in treatment of complicated skin and soft-tissue infections. Antimicrob Agents Chemother. 2005;49:2260-2266. (Pubitemid 40734452)
13. Stein GE, Craig WA. Tigecycline: a critical analysis. Clin Infect Dis. 2006;43:518-524. (Pubitemid 44157163)
14. Luh KT, Hsueh PR, Teng LJ, et al. Quinupristin-dalfopristin resistance among Gram-positive bacteria in Taiwan. Antimicrob Agents Chemother. 2000;44:3374-3380.
15. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193:172-179.
16. Creech CB, Kernodle DS, Alsentzer A, et al. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infec Dis J. 2005;24:617-621. (Pubitemid 40993616)
17. Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971-979. (Pubitemid 39313452)
18. Davis KA, Stewart JJ, Crouch HK, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39:776-782. (Pubitemid 39244289)
19. Harbath S, Dharan S, Liassine N, et al. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43(6):1412-1416. (Pubitemid 29259335)
20. Ellis MW, Griffith ME, Dooley DP, et al. Targeted intranasal mupirocin to prevent colonization and infection by communityassociated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother. 2007;51(10):3591-3598. (Pubitemid 47519348)
21. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis. 2007;44:178-185. (Pubitemid 46079977)
22. Dryden MS, Dailly S, Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect. 2004;56:283-286. (Pubitemid 38444080)
23. Koning S, van der Wouden JC, Chosidow O, et al. Efficacy and safety of retapamulin ointment of impetigo: randomized doubleblind multicentre placebo-controlled trial. Br J Dermatol. 2008;128:1077-1082. (Pubitemid 351521449)
24. Parish LC, Jorizzo JL, Breton JJ, et al. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: Results of a randomized controlled trial. J Am Acad Dermatol. 2006;55:1003-1013. (Pubitemid 44716499)
25. Champney WS, Rodgers WK. Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. Antimicrob Agents Chemother. 2007;51:3385-3387. (Pubitemid 350067559)
26. Kniehl E, Becker A, Foster DH. Bed, bath and beyond: pitfalls in prompt eradication of methicillin-resistant Staphylococcus aureus carrier statues in healthcare workers. J Hosp Infect. 2005;59:180-187. (Pubitemid 40197779)